Papers - YAMAMOTO Hayato
-
The cell surface hyaluronidase TMEM2 regulates cell adhesion and migration via degradation of hyaluronan at focal adhesion sites
Irie F, Tobisawa Y, Murao A, Yamamoto H, Ohyama C, Yamaguchi Y.
JBC 2021.6
-
Significance of pelvic lymph node dissection during radical prostatectomy in high-risk prostate cancer patients receiving neoadjuvant chemohormonal therapy
Iwamura H, Hatakeyama S, Narita T, Ozaki Y, Konishi S, Horiguchi H, Kodama H, Kojima Y, Fujita N, Okamoto T, Tobisawa Y, Yoneyama T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C.
Sci Rep . 2022.1
-
The Cell Surface Hyaluronidase TMEM2 Regulates Cell Adhesion and Migration via Degradation of Hyaluronan at Focal Adhesion Sites
fumitoshi irie, yuki tobisawa, yu yamaguchi
journal of biological chemistry 2021.2
-
TMEM2 expression is downregulated as bladder cancer invades the muscle layer.
Yoneyama MS, Yoneyama T, Tobisawa Y, Yamamoto H, Hatakeyama S, Yoneyama T, Hashimoto Y, Suzuki T, Ohyama C.
Biochem Biophys Res Commun. 2022.7
-
The cell surface hyaluronidase TMEM2 is essential for systemic hyaluronan catabolism and turnover
Tobisawa Y, Fujita N, Yamamoto H, Ohyama C, Irie F, Yamaguchi Y.
JBC 2021.11
-
Characteristics of α2,3-sialyl N-glycosylated PSA as a biomarker for clinically significant prostate cancer in men with elevated PSA level
Yoneyama T, Yamamoto H, Sutoh Yoneyama M, Tobisawa Y, Hatakeyama S, Narita T, Kodama H, Momota M, Ito H, Narita S, Tsushima F, Mitsuzuka K, Yoneyama T, Hashimoto Y, Duivenvoorden W, Pinthus JH, Kakeda S, Ito A, Tsuchiya N, Habuchi T, Ohyama C.
Prostate. 2021.12
-
Impact of an optimized surveillance protocol based on the European Association of Urology substratification on surveillance costs in patients with primary high-risk non-muscle-invasive bladder cancer
Fujita N, Hatakeyama S, Okita K, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C.
PLoS One. 2023.2
-
Minimum incision endoscopic radical cystectomy in patients with malignant tumors of the urinary bladder: clinical and oncological outcomes at a single institution.
T Koie, C Ohyama, H Yamamoto, S Hatakeyama, S Kudoh, T Yoneyama, Y Hashimoto, N Kamimura
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 38 ( 11 ) 1101 - 1105 2012.11
-
Real-world effectiveness of nivolumab plus ipilimumab and second-line therapy in Japanese untreated patients with metastatic renal cell carcinoma: 2-year analysis from a multicenter retrospective clinical study (J-cardinal study)
Kojima T, Kato R, Sazuka T, Yamamoto H, Fukuda S, Yamana K, Nakaigawa N, Sugino Y, Hamamoto S, Ito H, Murakami H, Obara W.
Observational Study 2022.11
-
Can Erectile Dysfunction Severity Predict Major Adverse Cardiovascular Events in Men Undergoing Dialysis? A Prospective Cohort Study
Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C.
World J Mens Health. 2023.10
-
Humoral response to SARS-CoV-2 mRNA vaccine on in ABO blood type incompatible kidney transplant recipients treated with low-dose rituximab
Tomoko Hamaya 1, Shingo Hatakeyama 2, Tohru Yoneyama 3, Yuki Tobisawa 1, Hirotake Kodama 1, Takeshi Fujita 4, Reiichi Murakami 4, Kazuyuki Mori 1, Teppei Okamoto 1, Hayato Yamamoto 1, Takahiro Yoneyama 5, Yasuhiro Hashimoto 1, Hisao Saitoh 6, Shunji Narumi 7, Hirofumi Tomita 4, Chikara Ohyama
Science report 2023.9
-
Impact of nephroureterectomy on postoperative renal function in upper tract urothelial carcinoma: A multicenter retrospective study
Yoshiharu Okuyama 1, Shingo Hatakeyama 2, Ryuji Tabata 3, Daiji Fujimori 3, Yohei Kawashima 3, Toshikazu Tanaka 4, Naoki Fujita 1, Teppei Okamoto 1, Kazuyuki Mori 1, Hayato Yamamoto 1, Takahiro Yoneyama 5, Yasuhiro Hashimoto 1, Toshimitsu Matsuoka 6, Satoshi Sato 3, Chikara Ohyama 1
Int J urology 2023.8
-
Trends in the age of hospitalized patients with urological cancers: A 17-year experience
Noritaka Ishii 1, Shingo Hatakeyama 2, Hikari Miura 1, Ryuma Tanaka 1, Takuya Oishi 1, Hirotaka Horiguchi 1, Shogo Hosogoe 1, Naoki Fujita 1, Hiromichi Iwamura 1, Teppei Okamoto 1, Hayato Yamamoto 1, Takahiro Yoneyama 3, Yasuhiro Hashimoto 1, Chikara Ohyama
int. J urology 2023.7
-
Comparison of neoadjuvant chemohormonal therapy vs. extended pelvic lymph-node dissection in high-risk prostate cancer treated with robot-assisted radical prostatectomy
Takuya Oishi 1, Shingo Hatakeyama 2, Ryuji Tabata 3, Daiji Fujimori 3, Mamoru Fukuda 3, Tetsuo Shinozaki 3, Noritaka Ishii 1, Hiromichi Iwamura 1, Teppei Okamoto 1, Hayato Yamamoto 1, Takahiro Yoneyama 4, Yasuhiro Hashimoto 1, Satoshi Sato 3, Chikara Ohyama
Sci Rep. 2023.5
-
Oncological and functional outcomes of female reproductive organ-sparing radical cystectomy and ileal neobladder construction
Hikari Miura 1, Shingo Hatakeyama 2, Toshikazu Tanaka 3, Naoki Fujita 1, Hirotaka Horiguchi 1, Ryuma Tanaka 1, Daisuke Noro 4, Noriko Tokui 5, Teppei Okamoto 1, Hayato Yamamoto 1, Takahiro Yoneyama 6, Yasuhiro Hashimoto 1, Chikara Ohyama
Urol Oncorogy 2023.5
-
Relationship between lower urinary tract symptoms and frailty
Yusuke Ozaki , Shingo Hatakeyama , Atsushi Imai , Jung Songee , Osamu Soma , Kai Ozaki , Naoki Fujita , Teppei Okamoto , Hiromichi Iwamura , Hayato Yamamoto , Takahiro Yoneyama , Yasuhiro Hashimoto , Chikara Ohyama
int. J urology 2023.4
-
Association between Aortic Calcification Burden and the Severity of Erectile Dysfunction in Men Undergoing Dialysis: A Cross-Sectional Study
Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C.
World J Mens Health. 2023.4
-
Effects of apalutamide dose reduction on skin-related adverse events in patients with advanced prostate cancer: A multicenter retrospective study
Oishi T, Hatakeyama S, Tabata R, Fujimori D, Kawashima Y, Tanaka R, Ishii N, Miura H, Tanaka T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Sato S, Ohyama C.
Multicenter Study 2023.2
-
Trends of incidence and age in adults with testicular germ cell tumors: a two-decade multicenter retrospective study
Ozaki Y, Narita T, Hatakeyama S, Tanaka T, Togashi K, Hamaya T, Ozaki K, Ishi N, Oishi T, Tokui N, Mikami J, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C.
Transl Androl Urol . 2023.2
-
Can Erectile Dysfunction Severity Predict Major Adverse Cardiovascular Events in Men Undergoing Dialysis? A Prospective Cohort Study
Fujita N, Momota M, Ozaki Y, Tobisawa Y, Yoneyama T, Okamoto T, Yamamoto H, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C.
World J Mens Health 2023.1